ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 139021 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 139021; 2) Community: the network communities that were significantly associated with the response to NSC 139021; 3) Molecule: the relationships between components within communities and NSC 139021; 4) MDR: the compounds that were significantly associated with the NSC 139021.

NSC Compound Enrichment Correlation
NSC 759216 (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone 0.0339770934764508 0.055707146
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0339770934764508 0.41199023
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0339770934764516 0.38159701
NSC 136468 Null 0.0339770934764516 0.4888759
NSC 126668 Null 0.035202825328704 -0.04661514
NSC 275971 Null 0.0352028253287042 0.27869034
NSC 305802 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- 0.0352028253287042 0.12147425
NSC 325268 Null 0.0352028253287042 0.3792331
NSC 357114 CS-12350 0.0352028253287042 0.068903525
NSC 377852 Null 0.0352028253287042 0.57259762
Total:115  Current:83    [First] [Prev] [Next] [Last]